Compounds > selegiline

Page last updated: 2024-08-23

selegiline and naloxone

selegiline has been researched along with naloxone in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (7.69)	18.7374
1990's	1 (7.69)	18.2507
2000's	6 (46.15)	29.6817
2010's	5 (38.46)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Gozalbes, R; Pineda-Lucena, A	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dhawan, BN; Gupta, GP; Gupta, MB; Gurtu, S; Nath, C; Srimal, RC	1
Arnaldos, JD; Cremades, A; Milanés, MV; Vargas, ML	1
Grasing, K; He, S	1
Charkhpour, M; Ghaderi, M; Habibi-asl, B; Hassanzadeh, K; Parvizpour, A; Shakhsi, M	1

Reviews

1 review(s) available for selegiline and naloxone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

12 other study(ies) available for selegiline and naloxone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations	2002
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Novel effects of MPTP: MAO-B unrelated opioidergic activity in mice. Neuroreport, 1991, Volume: 2, Issue:8 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analgesia; Animals; Female; Isoenzymes; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase; Naloxone; Narcotics; Posture; Reference Values; Selegiline	1991
Effect of selective monoamine oxidase inhibitors on the morphine-induced hypothermia in restrained rats. General pharmacology, 1987, Volume: 18, Issue:2 Topics: Animals; Body Temperature; Clorgyline; Dose-Response Relationship, Drug; Drug Interactions; Female; Male; Monoamine Oxidase Inhibitors; Morphine; Naloxone; Phenethylamines; Rats; Rats, Inbred Strains; Selegiline	1987
Effects of high-dose selegiline on morphine reinforcement and precipitated withdrawal in dependent rats. Behavioural pharmacology, 2005, Volume: 16, Issue:1 Topics: Acoustic Stimulation; Analgesics, Opioid; Animals; Conditioning, Operant; Cues; Dopamine; Eating; Male; Monoamine Oxidase Inhibitors; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Photic Stimulation; Rats; Rats, Wistar; Reinforcement Schedule; Reinforcement, Psychology; Selegiline; Self Administration; Substance Withdrawal Syndrome	2005
Repeated central administration of selegiline attenuated morphine physical dependence in rat. Pharmacological reports : PR, 2013, Volume: 65, Issue:3 Topics: Animals; Infusions, Intraventricular; Male; Morphine; Morphine Dependence; Naloxone; Rats; Rats, Sprague-Dawley; Rats, Wistar; Selegiline; Substance Withdrawal Syndrome; Substance-Related Disorders	2013